Equities

Sareum Holdings PLC

SAR:LSE

Sareum Holdings PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)25.88
  • Today's Change1.63 / 6.72%
  • Shares traded577.88k
  • 1 Year change-81.84%
  • Beta-0.7453
Data delayed at least 20 minutes, as of May 07 2024 11:23 BST.
More ▼

Financials data is unavailable for this security.

Cash flow in GBPView more

In 2023, cash reserves at Sareum Holdings PLC fell by 3.27m. However, Cash Flow from Investing was flat, indicating that little new money was committed to growth. In addition the company used 3.27m for operations while cash from financing was breakeven.
Cash flow per share-0.0615
Price/Cash flow per share--
Book value per share0.0059
Tangible book value per share0.0059
More ▼

Balance sheet in GBPView more

Sareum Holdings PLC has little financial risk as the capital structure does not rely on leverage.
Current ratio3.93
Quick ratio--
Total debt/total equity0.00
Total debt/total capital0.00
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.